REZOLUTE, INC. Earnings Per Share (Basic)
REZOLUTE, INC. (RZLT) reported Earnings Per Share (Basic) of -$0.75 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-24
- REZOLUTE, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.16.
- REZOLUTE, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.22.
- REZOLUTE, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.18.
- REZOLUTE, INC. earnings per share, basic for the quarter ending 2025-03-31 was -$0.27.
- REZOLUTE, INC. earnings per share, basic for fiscal 2026 was -$0.75.
- REZOLUTE, INC. earnings per share, basic for fiscal 2025 was -$0.98.
- REZOLUTE, INC. earnings per share, basic for fiscal 2024 was -$1.33.
- REZOLUTE, INC. earnings per share, basic for fiscal 2023 was -$1.01.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed | Earnings Per Share, Basic 36 month | Earnings Per Share, Basic 42 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.75 10-K · filed 2026-09-24 | ||||||
| 2026-03-31 | -$0.16 10-Q · filed 2026-05-12 | -$0.55 10-Q · filed 2026-05-12 | |||||
| 2025-12-31 | -$0.22 10-Q · filed 2026-02-12 | -$0.40 10-Q · filed 2026-02-12 | |||||
| 2025-09-30 | -$0.18 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | -$0.98 10-K · filed 2026-09-24 | ||||||
| 2025-03-31 | -$0.27 10-Q · filed 2026-05-12 | -$0.72 10-Q · filed 2026-05-12 | |||||
| 2024-12-31 | -$0.22 10-Q · filed 2026-02-12 | -$0.45 10-Q · filed 2026-02-12 | |||||
| 2024-09-30 | -$0.22 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | -$1.33 10-K · filed 2025-09-17 | ||||||
| 2024-03-31 | -$0.34 10-Q · filed 2025-05-13 | -$0.89 10-Q · filed 2025-05-13 | |||||
| 2023-12-31 | -$0.27 10-Q · filed 2025-02-12 | -$0.55 10-Q · filed 2025-02-12 | |||||
| 2023-09-30 | -$0.28 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | -$1.01 10-K · filed 2024-09-19 | ||||||
| 2023-03-31 | -$0.30 10-Q · filed 2024-05-15 | -$0.76 10-Q · filed 2024-05-15 | |||||
| 2022-12-31 | -$0.26 10-Q · filed 2024-02-13 | -$0.46 10-Q · filed 2024-02-13 | |||||
| 2022-09-30 | -$0.19 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | -$2.26 10-K · filed 2023-09-14 | ||||||
| 2022-03-31 | -$0.65 10-Q · filed 2023-05-11 | -$2.30 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | -$0.80 10-Q · filed 2023-02-10 | -$1.69 10-Q · filed 2023-02-10 | |||||
| 2021-09-30 | -$0.92 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | -$2.72 10-K · filed 2022-09-15 | ||||||
| 2021-03-31 | -$0.44 10-Q · filed 2022-05-12 | -$1.94 10-Q · filed 2022-05-12 | |||||
| 2020-12-31 | -$0.88 10-Q · filed 2022-02-09 | -$1.54 10-Q · filed 2022-02-09 | |||||
| 2020-09-30 | -$0.62 10-Q · filed 2021-11-12 | ||||||
| 2014-06-30 | -$1.04 10-K · filed 2014-09-30 | ||||||
| 2013-09-30 | -$0.02 10-Q · filed 2013-11-12 | -$0.24 10-Q · filed 2013-11-12 | |||||
| 2013-06-30 | -$1.08 10-K · filed 2014-09-30 | -$0.18 10-K · filed 2013-09-11 | |||||
| 2013-03-31 | -$0.12 10-Q · filed 2013-05-15 | -$0.16 10-Q · filed 2013-05-15 | -$0.20 10-Q · filed 2013-05-15 | ||||
| 2012-09-30 | -$0.02 10-Q · filed 2013-11-12 | ||||||
| 2012-06-30 | -$0.01 10-K · filed 2013-09-11 | ||||||
| 2012-03-31 | -$0.01 10-Q · filed 2013-05-15 | -$0.02 10-Q · filed 2013-05-15 | |||||
| 2011-12-31 | -$0.02 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |